Baroreflex stimulation: A novel treatment option for resistant hypertension.
Hypertension is a major public health problem in both developing and developed countries. Despite the increasing awareness of hypertension and its implications among patients and the treating physicians, the prevalence of resistant hypertension remains high and is expected to increase. Many patients fail to reach their target blood pressure (BP) despite the wide availability of several antihypertensive agents and the continued recommendation of dietary and lifestyle modifications. Stimulation of the carotid sinus results in lowering of BP by initiating the baroreflex and, in so doing, reducing sympathetic tone and increasing renal excretory function, in part, by exerting inhibitory effects on renin secretion. Recent evidence from experimental studies suggests that the baroreflex may be more important in the setting of chronic hypertension than originally believed. In early-phase clinical trials that did not include control arms, implantation of a baroreflex stimulator yielded a sustained decrease in BP. An ongoing larger clinical trial with appropriate control arms is further exploring the safety and efficacy of the device. This article describes the history and potential mechanisms of action of this device including its extensive preclinical development and movement to human clinical trials.
Navaneethan
Sankar D
SD
Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Lohmeier
Thomas E
TE
Bisognano
John D
JD
N Engl J Med. 2007 Jun 7;356(23):2388-98
17554120
N Engl J Med. 2006 Jul 27;355(4):385-92
16870917
Lancet. 2005 Jan 15-21;365(9455):217-23
15652604
J Vasc Surg. 2006 Dec;44(6):1213-1218
17145423
Lancet. 2001 Oct 20;358(9290):1305-15
11684211
JAMA. 2003 May 21;289(19):2560-72
12748199
Hypertension. 2005 Sep;46(3):540-6
16061731
Hypertension. 2007 Feb;49(2):373-9
17159083
Curr Opin Nephrol Hypertens. 2007 Sep;16(5):403-8
17693753
Lancet. 2007 Aug 18;370(9587):591-603
17707755
Eur J Vasc Endovasc Surg. 2007 Apr;33(4):414-21
17227715
Artif Organs. 1989 Apr;13(2):133-43
2784961
Acta Physiol Scand. 1958 Nov 18;44(2):138-45
13605814
Ann Biomed Eng. 1980;8(4-6):445-58
7294460
Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R434-43
11448845
Ann N Y Acad Sci. 2001 Jun;940:1-19
11458669
Circulation. 1969 Jan;39(1):48-54
4302539
Hypertension. 2004 Feb;43(2):306-11
14707159
Am J Surg. 1967 Jul;114(1):5-15
6026450
Hypertension. 1988 Mar;11(3 Pt 2):II71-5
3350596
Am J Physiol Regul Integr Comp Physiol. 2002 Apr;282(4):R1044-53
11893608
Hypertension. 2003 Jul;42(1):96-102
12771049
Am J Hypertens. 2001 Jun;14(6 Pt 2):147S-154S
11411750
Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R828-36
15793036
Hypertension. 2002 Feb;39(2 Pt 2):550-6
11882606
JAMA. 1965 Feb 22;191:649-53
14242423
Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R863-71
15563576
Hypertension. 2005 Nov;46(5):1194-200
16216987
Am J Physiol Regul Integr Comp Physiol. 2000 Oct;279(4):R1437-48
11004014
Hypertension. 2007 Jun;49(6):1307-14
17438305
Am J Hypertens. 2000 Jun;13(6 Pt 2):99S-105S
10921528
J Hypertens. 2003 Jun;21(6):1055-76
12777939
Circ Res. 1956 Mar;4(2):205-10
13293821
Ann N Y Acad Sci. 2001 Jun;940:132-41
11458672
Surgery. 1967 Jun;61(6):923-31
6026140